4 Hour Medication Assisted Treatment (MAT) Waiver Training hosted by Rochester Regional Health. Course will be facilitated by Fatma Akmese MD & Mayra Rodriguez PA Clinton Family Health Center MAT Program.
Under current regulations, authorized practitioners (MDs, DOs, NPs & PAs) are required to obtain a ‘waiver’ to prescribe buprenorphine. To acquire this waiver, physicians are required to complete a standardized buprenorphine waiver 8-hour training. Nurse Practitioners (NPs) and Physician Assistants (PAs) are required to complete the standardized buprenorphine waiver 8-hour training as well as an additional 16 hours of online training as established by the Comprehensive Addiction and Recovery Act (CARA). Residents may also take the course and apply for their waiver once they receive their DEA license. The buprenorphine waiver 8-hour training is offered in a ‘half and-half’ format [4 hours of in-person training followed up by 4 hours of online training]. Upon completion of the required training, providers will meet the requirement of the DATA 2000 to apply for a waiver to prescribe buprenorphine for opioid-dependent patients. Please contact us for further information.
CME CREDITS: The University of Rochester School of Medicine and Dentistry designates this live activity for a maximum of 4.50 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. The University of Rochester School of Medicine and Dentistry is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. CME Approval for the 4 hour in person course in currently pending.
ACCREDITATION: This activity has been planned and implemented by Rochester Regional Health in accordance with the accreditation requirements and policies of the American Academy of Addiction Psychiatry (AAAP).
Light breakfast will be provided
This training is supported by Delivery State Reform Incentive Program (DSRIP), Monroe County Health Department & Provider Clinical Support System(PCSS). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the Centers for Disease Control and Prevention or the Department of Health and Human Services.
Funding for this initiative was made possible (in part) by grant no. 5U79TI026556-03 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
AAAP's CE program aims to provide educational information that is balanced, independent, objective and free of bias and based on evidence. In order to resolve any identified Conflicts of Interest, disclosure information from all series planners and speakers is provided during the planning process to ensure resolution of any identified conflicts. The following PCSS-MAT, CPD Committee and AAAP staff members have reported that they have no commercial relationships relevant to the content of this activity to disclose: Stephen Wyatt, DO, Sanchit Maruti, MD, Thomas Penders, MD, Michael Goedde, MD, Kevin Sevarino, MD, Nitigna Desai, MD, Kathryn Cates-Wessel, Justina Andonian, Miriam Giles, Seth Acton, Marie Samson and Erin Waters. The Buprenorphine Waiver Training is supported in part by Overdose Data to Action, funded by the Centers for Disease Control and Prevention.
